STAAR Low-Grade Serous Ovarian Cancer

Survive. Thrive. Advocate. Advance Research. The first U.S. nonprofit dedicated to finding a cure for low-grade serous ovarian cancer.

[STAAR Low-Grade Serous Ovarian Cancer @staarovarian]

There is no such thing as too young for ovarian cancer #ovariancancerawarenessmonth #LGSOCawarenessday #lowgradeserousovariancancer

[Not These Ovaries @NotTheseOvaries]

Standard ovarian cancer treatments often fail LGSOC patients.
But promising research is emerging—if we fund it.

https://t.co/IrhEpBuHqi

[STAAR Low-Grade Serous Ovarian Cancer @staarovarian]

Thanks to @KozasInc for supplying our symptom awareness shirts each year. Hosts of STAAR fundraisers get 50 to pass out to participants, to turn them into Human Billboards!

Learn more at https://t.co/IBkRvacnGB.
#ovariancancerawarenessmonth #LGSOCawarenessday

[STAAR Low-Grade Serous Ovarian Cancer @staarovarian]

Show your support for LGSOC Awareness Day and alert your friends that September 9 is the day!

Get the template at https://t.co/KRvQ9Bm0iF.
#NewProfilePic

[STAAR Low-Grade Serous Ovarian Cancer @staarovarian]

Share this podcast with everyone you know. The story of STAAR board member Ellie Habib’s cancer diagnosis and fertility sparing is truly jaw-dropping.
#rarecancer #lgsoc #reproductivehealth #surrogacyjourney

Have a listen.
https://t.co/G9IBaMG2jK

[STAAR Low-Grade Serous Ovarian Cancer @staarovarian]

Wear Teal Day is the first Friday of Ovarian Cancer Awareness Month: Sept 5. Need something teal? Check out https://t.co/hMPU6B4V2r

#LGSOCAwarenessDay #LGSOCDay #LGSOC #ShareTheSignsSaveALife
#OvarianCancerAwareness #weartealday

[STAAR Low-Grade Serous Ovarian Cancer @staarovarian]

Are you in? https://t.co/ZAb9WLxs5g #LGSOCDay #LGSOC #ShareTheSignsSaveALife
#OvarianCancerAwareness

[STAAR Low-Grade Serous Ovarian Cancer @staarovarian]

🎧 Podcast fans! Check out Teal Time with Hope's interview with STAAR Vice Chair–Marketing & Communications Kari Neumeyer to learn about her unusual diagnosis story and what led her to volunteer with STAAR. 🌟
https://t.co/NxVajyZ4vj

#lgsoc #rarecancer #ovariancancer

[STAAR Low-Grade Serous Ovarian Cancer @staarovarian]

Another exciting development as we move toward finding effective treatments for recurrent low-grade serous ovarian cancer.

​Latest Research Expands on Efficacy of FDA-Approved LGSOC Treatment. #lgsoc #rarecancer

https://t.co/XGR1FDXDXD

[STAAR Low-Grade Serous Ovarian Cancer @staarovarian]

🧬 Exciting news! We are seeking proposals for 2026 research grants.

ℹ️ Learn more at https://t.co/3YDiWFa6gd. If you have any questions, please email [email protected] #lgsoc #cancerresearch #raredisease

[STAAR Low-Grade Serous Ovarian Cancer @staarovarian]

A question that comes up often after an ovarian cancer diagnosis is: Why don’t they test everyone’s CA 125?

The answer is complicated.

[Not These Ovaries @NotTheseOvaries]

Understanding your CA125 test results starts with knowing what this protein actually does in your body.

Our new guide breaks down the science behind CA125, the ROMA algorithm, and exciting advances in ovarian cancer screening research.
https://t.co/bN4Uij9hqa

[Susana Banerjee @BanerjeeSusana]

Phase 2 RAMP201 (ENGOTov60/GTG-UK/GOG3052)trial leading to FDA accelerated approval avumetinib and defactinib now published @JCO_ASCO @VerastemOncolog First approved therapy for low grade serous ovarian cancer. Thanks all. @ESGO_society @GOG @myESMO

[STAAR Low-Grade Serous Ovarian Cancer @staarovarian]

In the latest STAAR blog, Kate Kander talks about the danger of turning to TikTok for medical advice, and the importance of advocating for ourselves when doctors dismiss our symptoms. #lowgradeserousovariancancer #lgsoc

https://t.co/40dIQF4P00

[STAAR Low-Grade Serous Ovarian Cancer @staarovarian]

Results of the FRAME trial, which showed that avutometinib and defactinib could be used to successfully treat low-grade serous ovarian cancer, have been published in the journal @NatureMedicine #lgsoc #rarecancerresearch #ayacancer

https://t.co/q4MHWy770c

[STAAR Low-Grade Serous Ovarian Cancer @staarovarian]

Study uncovers how benign borderline ovarian tumors develop into invasive low-grade serous carcinoma https://t.co/23h4QK2n1W

[STAAR Low-Grade Serous Ovarian Cancer @staarovarian]

“These findings suggest that ctDNA screening is not a sufficiently robust method for detecting KRAS mutations in patients with LGSOC.”

https://t.co/7MCWBcFyLD

[Medscape @Medscape]

While a ‘menopause boom’ signals a new era of awareness, experts warn that deep-seated systemic bias continues to harm women's health, from diagnostics to clinical care. https://t.co/Q7t7CaDPQi

[World Ovarian Cancer Coalition @WOCCnews]

💙 We reached 52 million+ people for #WorldOvarianCancerDay 2025! 🌍

Thank you to everyone who helped us shine a light on #ovariancancer.

Read the full impact report: https://t.co/CRYw2eYJTK
#WOCD2025 #NoWomanLeftBehind

[Not These Ovaries @NotTheseOvaries]

Borderline ovarian cancer occupies a unique space between benign and malignant—and that's exactly why it's so misunderstood.

Our guide explains what you need to know: https://t.co/P91YQOMXgK

[STAAR Low-Grade Serous Ovarian Cancer @staarovarian]

What you need to know about the first FDA-approved treatment for #lowgraderserousovariancancer #LGSOC #cancerresearch https://t.co/RU0BeqdMme